Sort   by:  
 Page size 
0
UnknownEfficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.
Not available
S-EPMC5131925 | biostudies-literature
0
UnknownSubstrates and Inhibitors of SAMHD1.
Not available
S-EPMC5207538 | biostudies-literature
0
UnknownSynthesis of 4'-Substituted Carbocyclic Uracil Derivatives and Their Monophosphate Prodrugs as Potential Antiviral Agents.
Not available
S-EPMC9962574 | biostudies-literature
0
UnknownN4-Hydroxycytidine/molnupiravir inhibits RNA virus-induced encephalitis by producing less fit mutated viruses.
Not available
S-EPMC11493283 | biostudies-literature
0
UnknownIncreased activity of unlinked Zika virus NS2B/NS3 protease compared to linked Zika virus protease.
Not available
S-EPMC7712628 | biostudies-literature
0
UnknownRepurposing Nucleoside Analogs for Human Coronaviruses.
Not available
S-EPMC7927863 | biostudies-literature
0
UnknownDiscovery of a Series of 2'-α-Fluoro,2'-β-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C Virus.
Not available
S-EPMC7722249 | biostudies-literature
0
UnknownStably-Inverted Apical-Out Human Upper Airway Organoids for SARS-CoV-2 Infection and Therapeutic Testing.
Not available
S-EPMC10802305 | biostudies-literature
0
UnknownThe structural and mechanistic bases for the viral resistance to allosteric HIV-1 integrase inhibitor pirmitegravir.
Not available
S-EPMC10849636 | biostudies-literature
0
UnknownThe structural and mechanistic bases for the viral resistance to allosteric HIV-1 integrase inhibitor pirmitegravir.
Not available
S-EPMC11559089 | biostudies-literature
Sort   by:  
 Page size